Strata Critical Medical (SRTA) director Reginald Love sells 5,091 shares at $5.75

Rhea-AI Filing Summary

Strata Critical Medical, Inc. director Reginald Love reported a sale of 5,091 shares of Class A common stock on August 10, 2026 at $5.75 per share in an open market or private transaction. Following this sale, he directly holds 146,481 shares of the company’s common stock.

Insider Trade Summary

Net Seller: 5,091 shares

Net Sell 1 txn

Insider Love Reginald

Role Director

Sold 5,091 shs ($29K)

Type	Security	Shares	Price	Value
Sale	Class A common stock, $0.0001 par value per share	5,091	$5.75	$29K

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 146,481 shares (Direct)

Key Figures

Shares sold: 5,091 shares Sale price: $5.75 per share Shares held after transaction: 146,481 shares +1 more

4 metrics

Shares sold 5,091 shares Class A common stock sale on August 10, 2026

Sale price $5.75 per share Price for the 5,091 shares of Class A common stock sold

Shares held after transaction 146,481 shares Direct ownership position following the August 10, 2026 sale

Par value per share $0.0001 per share Par value of Strata Critical Medical, Inc. Class A common stock

Key Terms

Class A common stock, par value, open market or private transaction

3 terms

Class A common stock financial

"security_title: Class A common stock, $0.0001 par value per share"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

par value financial

"Class A common stock, $0.0001 par value per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

FAQ

What insider transaction did SRTA director Reginald Love report?

Reginald Love reported selling 5,091 shares of Strata Critical Medical, Inc. Class A common stock on August 10, 2026. The transaction was reported as a sale in an open market or private transaction at $5.75 per share.

How many SRTA shares did Reginald Love sell and at what price?

Reginald Love sold 5,091 shares of Strata Critical Medical, Inc. at a price of $5.75 per share. The transaction involved Class A common stock with a par value of $0.0001 per share.

How many Strata Critical Medical (SRTA) shares does Reginald Love hold after the sale?

After the reported sale, Reginald Love directly holds 146,481 shares of Strata Critical Medical, Inc. Class A common stock. This figure reflects his direct ownership position following the August 10, 2026 transaction.

Was the SRTA insider transaction by Reginald Love a purchase or a sale?

The reported transaction by Reginald Love was a sale of Strata Critical Medical, Inc. shares. It is coded as a sale in an open market or private transaction, with 5,091 shares disposed at $5.75 per share.

What type of security did Reginald Love trade in the SRTA Form 4 filing?

Reginald Love traded Class A common stock of Strata Critical Medical, Inc., with a par value of $0.0001 per share. The filing shows a non-derivative transaction involving 5,091 shares sold on August 10, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 05:33 PM Accepted by SEC EDGAR 08/13/2026 - 05:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Love Reginald

(Last) (First) (Middle)

C/O STRATA CRITICAL MEDICAL, INC.

666 THIRD AVENUE, 25TH FLOOR

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, $0.0001 par value per share	08/10/2026		S		5,091	D	$5.75	146,481	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Melissa M. Tomkiel, as attorney-in-fact for Reginald Love	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)